An adolescent with HIV/AIDS presented subacutely with progressive encephalopathy, spastic quadraplegia, and diarrhea. His brain biopsy was suggestive of central nervous system Whipple's disease, a disease rarely described in HIV patients. Due to overlapping, nonspecific symptoms associated with several opportunistic infections and to the difficulty in culturing the causative organism Tropheryma whipplei, Whipple's disease may be more common than previously suspected, and it is an important consideration in patients with AIDS.
Whipple's disease is rare; less than 1000 cases are described in the literature. It is a slowly progressive disease caused by Tropheryma whipplei, which involves multiple organ systems and often mimics other diseases. We report our experience with a potential presentation of Whipple's disease in a patient with AIDS. A 17- year-old adolescent male with a past medical history significant for perinatally acquired HIV/AIDS was admitted to the hospital for fever, mental status changes, and new onset left hemiparesis. By history, he had been poorly adherent with his HIV medications throughout adolescence and had not taken his combination therapy for more than 1 year. Two months prior to admission, his HIV plasma RNA (ribonucleic acid) was greater than 750 000 copies/mL and his CD4 count was 13 cells/μL. He had been prescribed atovaquone and azithromycin prophylaxis by his regular physician. His HIV-related complications had been pneumonia and sinusitis; otherwise, he had no known opportunistic infections. In addition, it was reported that he had had a significant personality change over the past 2 years, becoming more argumentative and disruptive at home and at school.
Case Report
On the day of admission to our institution, his temperature was 38.5°C with a normal heart rate, respiratory rate, and blood pressure. He was obtunded with equal bilateral pupillary response but diminished gag reflex. He had increased bilateral patellar and plantar reflexes (left greater than right), but no sustained clonus. There was no hepatosplenomegaly and only localized inguinal lymphadenopathy. His admission complete blood count revealed 3500 cells/mm 3 with a normal differential. His serum chemistries and liver function tests were normal, except for an elevated total protein (9.2 g/dL). After 5 hours, his mental status normalized; however, he had persistent dysarthria and generalized asymmetric spastic quadraparesis. He was admitted to the intensive care unit for further diagnostic evaluation and airway observation.
A noncontrast head computed tomographic (CT) scan showed multiple hypodensities in the right insular region, left thalamic/posterior limb of internal capsule, and bilateral centrum semi ovale. Cerebrospinal fluid (CSF) analysis revealed a white cell blood count of 3 cells/mm 3 and red cell blood count of 110 cells/mm 3 . CSF glucose and protein were 67 mg/dL and 32 mg/dL, respectively. CSF gram stain, KOH (Gram and potassium hydroxide) stain, acid fast bacilli (AFB) stain, VDRL (venereal disease research laboratory), Toxoplasma antibody, and Cryptococcus antigen assay were all negative. A magnetic resonance imaging (MRI) study revealed multiple abnormal hyper-intense, nonenhancing foci on diffusion-weighted images present over the thalamus, pons, and medulla (left greater than right), which corresponded to CT scan findings. Magnetic resonance angiography and venography studies showed no evidence of large vessel stenosis, aneurysm, or thrombosis. Laboratory evaluation for coagulation abnormalities was normal.
He received empiric treatment with ceftriaxone, vancomycin, and acyclovir for 5 days, as further diagnostic studies were performed. An electroencephalography study demonstrated diffuse slowing without epileptiform activity. Echocardiogram and ophthalmic exam were both within normal limits. CSF bacterial, fungal, AFB, and viral cultures were all negative, as were the CSF DNA polymerase chain reactions (PCRs) for herpes simplex virus, cytomegalovirus (CMV), Ebstein-Barr virus (EBV), and enterovirus. His serum rapid plasma reagin was nonreactive, and serum titers for CMV, EBV, B burgdorferi, Toxoplasma, and adenovirus were also negative.
His speech and motor activity progressively worsened with increased cranial nerve weakness, horizontal gaze palsy, and quadraparesis. Two weeks after his admission, he developed rigors, became obtunded, and required intubation. The differential diagnosis at this time included lymphoma, acute demyelinating encephalomyelitis, and progressive multifocal leukoencephalopathy (PML). He was started on cidofovir for treatment of PML and received doses of intravenous immunoglobulin for acute demyelinating encephalomyelitis, both without improvement. He also developed progressively worsening chronic diarrhea and weight loss. Multiple tests of his stool were negative, including bacterial culture, rotavirus enzyme immunoassay, adenovirus enzyme immunoassay, ova and parasite exam, AFB culture, trichrome stain for protozoa, immunochromotographic assay for Giardia, and modified acid stain for Cyclospora, Cryptosporidium, and Isospora. In addition, multiple CSF, tracheal secretion, and blood isolator samples were negative for Mycobacterium avium complex (MAC). A gastric tube was placed for nutritional support.
His neurological condition continued to deteriorate, and he developed spastic quadriplegia. A repeat brain MRI revealed increased signals in the previous anatomic distribution. A brain biopsy was performed 3 weeks after his initial admission. Subcortical specimens of his left fronto-parietal region revealed a dense infiltrate of macrophages, which obliterated the underlying brain parenchyma. Inside the macrophages were numerous rod-shaped microorganisms that stained positive with Gomori methenamine silver, Gram, and Luxol-fast blue-Periodic acid Schiff (PAS) stains ( Figure 1 ). Special stains for mycobacteria (AFB and Fite) were negative, as were immunohistochemical stains for Toxoplasma and the SV40 antigen that might suggest JC (John Cunningham) virus. These findings were suggestive of Whipple's disease of the central nervous system (CNS).
For treatment of Whipple's disease, the patient received ceftriaxone for 1 month followed by daily ceftibuten. First-line therapy for Whipple's disease, trimethoprim-sulfamethoxazole, could not be given because of a drug allergy. In addition, CSF PCR results were reported positive for JC virus. Cidofovir was continued for 1 month, concurrent with ceftriaxone.
Initially, he did show some clinical improvement, including blinking of his eyes and squeezing of the examiner's hand on command; however, he worsened after 3 weeks and remained unconscious thereafter.
He progressively deteriorated over his subsequent hospital course. Despite both parenteral and gastric tube nutrition, he had persistent diarrhea and a 14 kg weight loss. Infectious complications included methicillin-resistant Staphylococcus aureus bacteremia, Candida albicans urinary tract infection, and vancomycinresistant Enterococcus urinary tract infection. He also developed a persistent left pleural effusion and SIADH (syndrome of inappropriate antidiuretic hormone secretion). He required tracheostomy because of intermittent apnea and chronic hypoventilation. His temperature and blood pressures remained labile, necessitating escalating doses of antihypertensives. Sequential CD4 counts did not show improvement, although his HIV plasma RNA fell below 10 000 copies/mL on a regimen of lamivudine, abacavir, tenofovir, and lopinavir-ritonavir. The patient developed worsening vital sign instability, and ventilator support was discontinued 3 months after his initial admission. The patient died 4 days later from progressive hypoxia and bradycardia.
Discussion
Whipple's disease is a rare, slowly progressive disease, caused by the bacterium Tropheryma whipplei. 1 The microorganism is an intracellular parasite, typically found in tissue macrophages. 2 It can have multiorgan system manifestations, most commonly diarrhea, cachexia, arthralgias, and recurrent fevers. 3 Central nervous system symptoms are found in up to 30% of patients, with typical pathological findings of a focal or diffuse encephalitis with macrophage infiltrates. 4 Gaze palsy, cognitive changes, or altered consciousness are the most common presenting symptoms. 5 Other case reports have described hypothalamic dysfunction, 6 similar to our patient, and a stroke-like presentation due to arterial thrombosis without active vasculitis. 5 Whipple's disease of any manifestation has been very rarely described in HIV patients. We performed a Medline/Pubmed search using the key search terms "Whipple's disease" or "Tropheryma whipplei" combined with "HIV" or "AIDS" and found only 3 other cases in the English literature. The first case was a 24-year-old woman with profound lymphopenia, oral candidiasis, weight loss, and fever. 7 No tissue diagnosis was obtained in the case, and in retrospect the infectious etiology was most likely MAC. Jankovic 8 described a 57-year-old man with chronic diarrhea, supranuclear ophthalmoparesis, and facial myoclonus. In this case, CNS biopsy revealed PAS-positive bacilli. These microorganisms were not labeled in AFB stains and cultures, as AFB were negative. Maiwald et al 9 detected T whipplei DNA by PCR from a jejunal biopsy of an AIDS patient with diarrhea.
T whipplei-specific PCR tests were performed on his brain biopsy specimen but were negative despite multiple attempts using 3 different PCR protocols. Unfortunately, PCR testing was done only postmortem, from paraffin-embedded brain biopsy tissue; therefore, we believe that the sensitivity of the test may have been compromised. We controlled for the DNA isolation protocol by performing a parallel amplification for the human CCR5 gene; amplicons of the correct size were produced, but the products were weak (data not shown). This result suggests that, if present, T whipplei target nucleic acids were likely below the limit of detection of our assays. PCR inhibitors were not detected in the samples in experiments using alternate amplification target and primers in a PCR reaction mix spiked with patient sample nucleic acids.
Despite these negative PCR results, we believe our patient likely had CNS Whipple's disease because of findings on brain biopsy (rod-shaped, Gram-positive, PAS-positive, AFB-negative intramacrophage microorganisms). We understand that our biopsy results are not diagnostic or pathognomonic for Whipple's disease. Ideally, immunohistochemistry staining of the brain biopsy specimen specific for T whipplei and/or PCR testing of CSF would have established the diagnosis; however, because most of our investigations were done postmortem, remaining sample was not available. Other microorganisms with similar clinical and pathological findings include atypical mycobacteria such as MAC, Rhodococcus, and Nocardia. However all of these bacteria are positive or weakly positive by AFB staining. Furthermore, blood, stool, and CSF AFB cultures were repeatedly negative for MAC. Although our patient did not have an intestinal biopsy, his persistent diarrhea and weight loss reflect the 2 most common symptoms of Whipple's disease. 10 His cognitive decline and gaze palsy are also characteristic of T whipplei infection. 11 His preceding personality changes may have been due to early neuropsychiatric manifestations of his Whipple's disease, as has been described elsewhere. 12 It is also possible that his neurological deterioration was due to simultaneous infection with T whipplei and JC virus. The fact that his biopsy tested negative for the SV-40 antigen, despite a positive CSF PCR, may have been due to the biopsy of an unaffected site. Although PML could explain his neurological and radiographic findings, the diagnosis by itself was not consistent with the biopsy findings. His failure to show a sustained response to the treatment against PML and Whipple's disease likely reflects his profound AIDS-related immune suppression. The ideal treatment regimen of CNS Whipple's disease remains undetermined, because the rarity of the disease precludes randomized clinical trials. We had treated our patient with ceftriaxone, which in one study has been shown to be inactive against T whipplei in fibroblast cell culture as measured by real-time PCR. 13 However, another study has shown T whipplei to be susceptible to ceftriaxone in axenic medium. 14 Furthermore, ceftriaxone has shown to be anecdotally effective in case reports of patients with CNS Whipple's disease. 15 Environmental studies have indicated that T whipplei is a ubiquitous microorganism, having been detected in sewage samples. 16 Furthermore, it has been detected in healthy controls from saliva and duodenal biopsies. 17, 18 A low disease incidence in the setting of common environmental and host reservoirs and a general lack of co-infection (unlike our patient) implicate a specific, subtle immune deficit.
Numerous immunological abnormalities have been described in Whipple's disease; however, macrophage dysfunction is understood to be the primary deficit. 19 Macrophages from Whipple's disease patients have been shown to degrade bacterial antigens inefficiently. 20 The expression of CD11b, the alpha chain of the phagocyte receptor CR3, is reduced causing dysfunction in macrophage phagocytosis. 21 Macrophage secretion of interleukin-12 (IL-12), an important cytokine for Th1 differentiation and interferon-gamma (IFN-γ) secretion (causing subsequent macrophage activation), is also decreased. 22 IL-4 is increased, leading to decreased macrophage activation and an increased Th2 rather than Th1 immune response. 23 Following HIV infection, macrophage dysfunction is well established. Macrophages obtained from HIVinfected individuals have defective phagocytosis of a variety of opportunistic pathogens such as Toxoplasma gondii. 24 HIV-1 impairs FcγR-mediated phagocytosis by inhibiting early signaling effects. 25 IL-12 production is decreased in HIV-1 infected macrophages, causing impaired Th1-type cellular immune responses necessary for combating intracellular pathogens. 26 Although HIV-infected patients may not have the specific macrophage abnormality that predisposes non-HIV-infected patients to developing Whipple's disease, we speculate that the macrophage abnormalities in HIV-infected patients predispose them to infections by intracellular pathogens such as T whipplei. Treatment options for both diseases may overlap. For example, IFN-γ has been used successfully to treat MAC infection in HIV patients 27 and refractory Whipple's disease. 28 Although not confirmed, we believe that our pediatric patient had CNS Whipple's disease, an important consideration for the clinician managing HIV-positive patients. The diagnosis should be suspected in AIDS patients with encephalopathy in the setting of a negative diagnostic evaluation for other etiologies. Furthermore, the diarrhea and weight loss associated with Whipple's disease can be clinically very similar to MAC colitis, fungal, or protozoan infection. As the microorganism is slow growing and extremely difficult to culture, Whipple's disease should be suspected in AIDS patients with chronic diarrhea of unknown etiology. Increased availability of PCR testing will likely lead to more reported cases in AIDS patients.
